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The disorders generally classified as physical 
urticarias include cold urticaria, local and general-
ized (cholinergic) heat urticaria , dermographism , 
pressure urticaria , and vibration-induced angio -
edema. These diseases have the" common property 
of being reproducibly induced by physical stimuli 
and are not associated with an increased incidence 
of allergic disorders such as hay fever or extrinsic 
asthma in which offending allergens are identifia-
ble. Studies of these diseases have involved at-
tempts to identify circulating antibodies that 
might be responsible for the observed sensitivity or 
to determine the release of vasoactive principles in 
response to the inciting stimulus. In this paper we 
will summarize studies of mediator release and the 
mechanism by which such release occurs in cold 
urticaria , cholinergic urticaria, and vibration-
induced angioedema. 
COLD URTICARIA 
Cold urticaria is characterized by the rapid 
development of hives and swelling after exposure 
to a cold stimulus. It can occur in any age group , 
has no predilection for either sex, and is not 
associated with other allergic disorders . The typi-
cal patient may become symptomatic while walk-
ing outside in the winter; however, pruritus and 
swelling are often most prominent when the person 
comes indoors and begins to warm. Only exposed 
portions of the body such as the face and hands are 
affected. Although cold foods such as ice cream 
may lead to swelling of the lips or tongue , pharyn-
geal or laryngeal edema are exceedingly rare and 
gastrointestinal symptoms are not seen. However , 
generalized exposure , for example while swim-
ming, can lead to such massive mediator release 
that hypotension, fainting , and drownings can 
result [1] . 
A simple diagnostic test which reproduces this 
l-i henomenon is to place an ice cube on the patient's 
i!)rearm for 5 min and then wait 10 min for any 
12action to occur. Although everyone has evidence 
r,f redness after the ice cube is removed , this 
Reprint requests to : Dr. A. P. Kaplan, Allergic Dis-
ases Section, Laboratory of Clinical Investigation, 
HAID, National Institutes of Health, Bethesda, Mary-
'and 20014. 
Abbreviations : 
ECF -A: eosinophil chemotactic factor of anaphylaxis 
PAF: Platelet activating factor 
SRS-A: slow reacting substance of anaphylaxis 
normally subsides during the next 5 min . The 
patient with cold urticaria usually complains of 
pruritus in the area between 2 and 4 min after 
removal of the ice cube and develops a large hive 
the size of the ice cube within 10 min. Figure 1 
shows the result of a positive ice cube test demon-
strating swelling which encompasses the area 
where the ice cube was placed as well as the area 
where ice water dripped down the patient's arm. 
In order to identify the mediators released in 
cold urticaria, patients were studied in the follow-
ing manner. An intravenous catheter was placed in 
the brachial vein and 5% dextrose in water was 
slowly infused. Baseline samples were obtained 
and the intravenous line was flushed with normal 
saline containing 15 U/ ml heparin in order to 
prevent local coagulation. The hand was then 
lowered into a bucket of ice water (O DC) and 
submerged to about 2 inches above the wrist for 4 
min. The hand was removed; a second sample was 
drawn; and subsequent samples were obtained 
after 2, 5, 8, 12, 15, and 20 min. A 5-ml sample was 
discarded immediately before each sample was 
collected in order to eliminate any intravenous 
fluid present in the catheter; the catheter was then 
flushed with heparinized saline. Samples for hista-
mine and serotonin determinations were drawn 
into 12-ml plastic syringes containing 100 U hepa-
rin (0.1 ml of a 1,000 U/ml solution). Ten milliliters 
of blood were drawn and spun for 20 min at 900 g , 
and the plasma was separated with Pasteur 
pipettes. Samples for bradykinin determinations 
were collected into ethylenediamine tetraacetate 
(9 mg/10 ml blood) and hexadimethrine bromide 
(3.6 mg/lO ml blood). 
Six patients with cold-induced urticaria were 
studied. Each had a positive ice cube test while 
tests for cryoglobulins, cold agglutinins, cryofi-
brinogen , and serology for syphilis were negative. 
The patients had a normal protein electrophoretic 
pattern and a normal serum IgE level. Samples 
were assayed for histamine by the radioenzymic 
procedure described by Beaven et al [2], while 
serotonin was determined by a double isotopic 
assay [3] based on the procedure of Saavadra et al. 
[4]. Bradykinin was assayed by radioimmunoassay 
[5.1 , 
The results of the assay for histamine release in 5 
patients are shown in Figure 2. Within 10 min after 
the ice water challenge, a wave of histamine was 
obtained, the peak values ranging from 10 to 36 
ng/ml. Patients complained of warmth and ·pruri-
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FIG . 1. Photograph of an ice cube test performed on a 
patient with cold urticaria. 
tus at about 2 min after removing the hand from 
the ice water. Swelling was observed between 2 and 
6 min , and peak histamine levels were obtained 
between 4 and 8 min. A single patient had a history 
of repeated episodes of hypotension caused by 
wading in the ocean up to his knees for a period of 
about 5 min. Such immersion caused flushing and 
light headedness that sometimes progressed to 
episodes of fainting. The assay for histamine 
release in this patient is shown in Figure 3. Four 
minutes after ice water challenge , the venous 
effluent from his hand contained 260 ng/ml hista-
mine. Also shown are the blood pressure recordings 
obtained during this period; between 2 and 5 min 
after challenge the patient flushed, was mildly 
diaphoretic, complained of tightness in his chest, 
and had a transient drop in diastolic blood pres-
sure of 50 points. Assays of the same samples in all 
6 patients contained no detectable serotonin or 
bradykinin. 
Passive transfer studies in cold urticaria were 
performed by injecting 0.1 ml of serum into each of 
two skin sites of the recipient and then challenging 
the sites with an ice cube 2 and 48 hr later as 
described above. All sera were prescreened to be 
sure they were Australia antigen-negative and free 
from bacterial contamination. Only lout of the 6 
patients studied had a positive test at 2 hr and at 
48 hr, suggesting an IgE-mediated reaction. This 
VoL. 67, No.3 
hypothesis was confirmed by passing the patient's 
serum over immunoadsorbents prepared with anti-
sera against myeloma proteins of the IgG, IgM, 
IgA, IgD , and IgE classes of immunoglobulin. Only 
the anti-IgE immunoadsorbent removed the activ-
ity from the patient's serum. 
CHOLINERGIC URTICARIA 
Cholinergic urticaria or generalized heat urti-
caria is induced by an increase in body tempera-
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FIG. 2. Study of histamine release after ice water 
challenge in 6 patients with cold urticaria. 
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FIG. 3. Histamine release (6) and blood pressure (e) 
recording in a cold urticaria patient who had a history of 
cold-induced hypotension. 
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ture associated with exposure to a hot stimulus or 
as a consequence of exercise or psychic stimuli [6, 
7]. Each of these challenges appears to initiate a 
neuroreflex which results in the elaboration of 
acetylcholine from parasympathetic and/or sym-
pathetic neurons followed by pruritus and urti-
caria. The lesions are characterized by small punc-
tate wheals surrounded by considerable erythema 
which tend to first appear over the upper thorax 
and neck. Patients appear to be "hypersensitive" 
to cholinergic stimuli since intradermal injection of 
mecholyl or acetylcholine produces a positive 
wheal and flare reaction often surrounded by 
smaller satellite lesions. This reactivity can be 
used as a test for cholinergic urticaria; it is 
diagnostic when satellite lesions are seen and is 
suggestive of the disorder if a wheal appears. 
Figure 4 summarizes the neuroreflex pathway 
thought to mediate cholinergic urticaria . Studies 
in support of such a scheme include the observa-
tion that if a tourniquet is placed on one arm of a 
patient and the hand immersed in warmed water , 
no local or systemic reaction is observed. However 
if the tourniquet is released , a systemic reaction 
results [8] suggesting that some central perception 
of the temperature change at the periphery is 
necessary . Since the tourniquet cannot interrupt 
afferent neurogenic stimuli it is assumed that 
perception of a temperature change in the venous 
effluent has occurred. 
Patients with cholinergic urticaria were studied 
with the same intravenous catheter setup used for 
cold urticaria. As a challenge, patients were 
instructed to run in place for 10 min and samples 
were obtained every 5 min for 35 min . In Figure 5 is 
shown a photograph of the hives which had devel-
oped in a patient 10 min after completing the 
exercise test . We have thus far studied 6 patients 
with cholinergic urticaria. In a single patient with 
extremely severe symptoms, a clear-cut increase in 
plasma histamine was observed as shown in Figure 
6. This patient had a positive mecholyl skin test 
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FIG. 4. Proposed neuroreflex mechanism leading to 
acetylcholine release in cholinergic urticaria. 
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with satellite lesions and, after exercise challenge, 
had markedly pruritic wheals over the entire body, 
many of which became confluent. After 5 min of 
exercise, an increase in plasma histamine was 
observed. It then rose abruptly to 25 ng/ml after 7 
to 8 min and gradually declined over the next half 
hour . In 2 of 4 other patients with milder symp-
toms, a positive mecholyl skin test without satel-
lite lesions was observed and a similar histamine 
release curve was obtained. However the peak 
levels reached were 3 ng/ml and 4 ng/ml, respec-
tively, while their baseline values were less than 1 
ng/m!. In the other 2 patients no elevation of 
plasma histamine was detected. The sixth patient, 
reported previously [9], had an atypical presenta-
tion because the lesions were not pruritic and no 
erythema was seen, but prominent wheals covered 
the entire body and the mecholyl skin test was 
FIG. 5. Photograph of a patient with cholinergic urti-
caria 10 min after exercise, showing the characteristic 
small , punctate wheals. 
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FIG. 6. Exercise-induced histamine release in a 
patient with cholinergic urticaria. 
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positive with numerous satellite lesions. This 
patient was studied twice and in each instance 
elevated baseline serotonin levels were obtained, 
which diminished, and then increased again during 
exercise. The time course of the serotonin values 
did not parallel the course of development of the 
patients' lesions. However, these repeatedly ele-
vated values were the only abnormal serotonin 
determinations in any of our patients. No detecta-
ble elevation of bradykinin was found in any 
patient with cholinergic urticaria. 
VIBRATION-INDUCED SWELLING 
In 1972, a family was described by Patterson et 
al [10], who presented with angioedema induced 
by vibratory stimuli such as rapidly moving a towel 
back and forth across the back. In order to design a 
reproducible challenge in these patients, a labora-
tory vortex was set at a fixed speed, the patient's 
arm rested on a surface, and the forearm gently 
placed upon the vortex for 4 min. When we studied 
this patient [11] with a catheter in the brachial 
vein of the arm being stimulated, a rapid rise in 
plasma histamine was obtained within 1 min of 
application of the stimulus, reaching a peak value 
of 53 ng/ml. Within 3 min the patient's forearm 
and half the arm swelled circumferentially. The 
stimulus was removed after 4 min, and by this time 
the plasma histamine level had begun to return to 
baseline. Thus, this familial disorder yielded the 
most rapid rise and fall of plasma histamine in re-
sponse to a physical stimulus that we have so far 
encountered. 
When we tested patients with cold urticaria, 
cholinergic urticaria, idiopathic chronic urticaria, 
and normals for vibration-induced swelling, we 
found that many people responded with localized 
angioedema extending over a slightly greater area 
than was in contact with the stimulus. We did not 
observe any response which yielded rapid circum-
ferential edema as did patients with the hereditary 
disorder. However, 2 patients with cholinergic 
urticaria responded with erythema, warmth, and 
swelling over most of the volar surface of the 
forearm. A facial flush could be reproducibly 
induced in 1 of these patients in response to this 
vibratory stimulus. We therefore studied both 
these patients in the manner described above . The 
results obtained in the patients and a normal 
control are shown in Figure 7. A rapid rise in 
plasma histamine was observed in the patients 
with a pattern identical to that observed in heredi-
tary vibratory angioedema; however the magni-
tude of the response was considerably less. The 
normal control did not have an elevation in plasma 
histamine in response to the stimulus. 
DISCUSSION 
Studies of histamine release in cold urticaria 
have not previously yielded reproducible results. 
Elevation of whole blood histamine in such 
patients after cold challenge was first reported by 
Vol. 67, No.3 
Rose [12] . Subsequently Henderson et al [13] 
obtained similar results; however, no control group 
of patients was included. Duner et al [14] found the 
blood histamine levels elevated in both cold urti-
caria patients and normal controls. Plasma hista-
mine determinations . have similarly yielded con-
flicting results. Beall [15] reported elevated plasma 
histamine levels in a single cold urticaria patient 
after cold challenge, while Spuzic and Ivkovic (16) 
reported no change in plasma histamine levels in 2 
cold urticaria patients. Utilizing the radioenzyme 
assay for histamine in heparinized plasma (or 
serum) we have been able to demonstrate elevated 
plasma histamine levels in all our cold urticaria pa-
tients. The time course of histamine release ap-
peared to coincide with the onset of pruritus and 
swelling. By comparison we found the determina-
tion of histamine in whole plasma by bioassay or 
fluorometric assay to be less sensitive and to give 
poor reproducibility. We did not detect elevated 
levels of either serotonin or bradykinin in these pa-
tients and cannot support the observations of 
DeLaus and Winkelman [17] who suggested that 
kinins may be critical mediators of cold urticaria. 
In a single patient, approximately 10 times the max-
imum histamine level of any other patient was ob-
tained at a time that significant hypotension was 
observed. We conclude that histamine release does 
occur in patients with cold urticaria as a conse-
quence of cold challenge, and it appears likely that 
it is the major mediator contributing to the pruri-
tus, swelling, and hypotension, characteristic of 
this disorder [9]. 
We found only a single patient in whom we could 
demonstrate an IgE-dependent mechanism by pas-
5ive transfer , although an incidence as high as 
two- thirds has been previously reported by Houser 
et al [18]. Wanderer et al [19] reported 2 patients 
in whom IgM appeared to be of pathogenic impor-
tance; however, we could not demonstrate passive 
transfer of cold urticaria after ei ther short (2-4 hr) 
or long (24-48 hr) latent periods in the 5 other 
patients. The mechanism by which a change in 
temperatuare could lead to mediator release is 
unknown although the critical cell would appear to 
be the tissue mast cell. Somehow this cell is 
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FIG. 7. Histamine release secondary to vibratory stim-
ulus in a normal control and in two patients with choliner- . 
gic urticaria and vibration-induced swelling. I 
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"sensitized" or activated by a drop in temperature 
followed by mediator release as the temperature 
increases. By analogy with the mechanism of 
mediator release in allergic rhinitis or extrinsic 
asthma it is likely that slow reacting substance of 
anaphylaxis (SRS-A) [20], the peptides designated 
eosinophil chemotactic factor of anaphylaxis 
(ECF -A) [21], and platelet activating factor (PAF) 
[27] are also released. However, we have not 
assayed for SRS-A or ECF -A and have obtained no 
evidence of P AF release since elevated plasma 
serotonin levels were not observed. We have re-
cently reported that histamine itself is also selec-
tively chemotactic for human eosinophils '-{23]; 
however, it is unlikely that the rapid release and 
clearing of the histamine observed could lead to 
local eosinophil accumulation. 
Less is known about the pathogenesis of cholin-
ergic urticaria. Although patients appear to be 
hypersensitive to cholinergic stimuli, and a neu-
roreflex mechanism appears to be operative, there 
is no evidence that the disease is immunoglobulin 
mediated and the mechanism by which cholinergic 
agents form a wheal is unknown. Our studies of 
mediator release in this disorder are not clear-cut. 
In some patients, no elevation of histamine, sero-
tonin, or bradykinin was detected. In 2 patients, 
elevated histamine levels were observed which 
appeared to correlate with the patients' response to 
exercise; and in a single, atypical patient, elevated 
serotonin levels were obtained which did not corre-
late well with the patient's course. Technical 
limitations may contribute to the negative findings 
observed in some patients since the urticaria 
involves the superficial layers of skin rather than 
the deep dermis or subcutaneous tissue (which are 
affected in cold urticaria). Furthermore, sampling 
a brachial vein during exercise can only reflect 
the systemic circulating level at that moment rather 
than the level directly draining the site being stim-
ulated. The results further suggest that this dis-
order may be heterogeneous since both the clini-
cal presentation and results of mediator release 
have not been uniform. 
Our evaluation of a patient with hereditary 
vibratory angioedema suggests some intrinsic 
defect of the patient's mast cells which leads to 
degranulation after the appropriate stimulus. The 
observation that a similar, although milder form of 
vibration-induced swelling is observed in some 
patients with cholinergic urticaria suggests that 
there may be a pathogenic relationship between 
the two disorders. They are nevertheless distinct 
clinical entities since none of these cholinergic 
urticaria patients complained of swelling induced 
by vibratory stimuli. 
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DISCUSSION 
Provost: Have you been able to find specific antibody 
activity for the serum IgE in your cold urticaria patients? 
Do they have positive skin tests? 
Kaplan: The patients in whom an IgE mechanism was 
demonstrable were not clinically atopic and the skin tests 
to our usual battery of antigens were negative, including 
ragweed. 
Austen: How would physical stimuli initiate IgE-
dependent reactions? 
Kaplan: In cold uticaria there are many possibilities 
that might explain the observed mediator release. One 
has to rule out an IgE cryoglobulin but evidence against 
this is the fact that passive sensitization of basophils 
from patients who have shown to be "acceptors" for IgE 
with the patient's plasma or isolated IgE does not release 
histamine upon chilling and warming the cells. This 
suggests that since skin is responsive we may be dealing 
with a mast cell which releases mediators when the 
temperature changes after an abnormal IgE binds to it, or 
that the patient has an IgE antibody to a temperature-
dependent skin antigen. 
Jordon: Soter and others have recently suggested that 
some forms of urticaria may be manifestations of sys-
temic vasculitis. In the patients with cholinergic urticaria 
without increased histamine levels, were any of these 
patients hypocomplementemic or was there any immuno-
fluorescent evidence in skin lesions suggestive of vasculi-
tis? 
Kaplan: The patients I described have no complement 
abnormality, no change in serum complement with 
challenge, and immunofluorescent staining of their tissue 
after challenge reveals no evident complement deposi-
tion. Bear in mind that some patients with cold urticaria 
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do have cryoglobulins or other abnormal circulating 
proteins, and in these cases the pathogenesis of their 
lesions may involve other pathways of mediator release. 
Sams: In another form of physical urticaria, namely 
solar urticaria, "reverse" passive transfer is possible; that 
is, exposure of the skin of the recipient to ultraviolet 
radiation followed by injection of the patient's serum will 
result in a hive . Mechanistically, this implies that 
ultraviolet releases one or more substances that may 
become antigenic in some individuals. Is this "reverse" 
passive transfer possible in cold urticaria? 
Kaplan: We have not observed positive ice cube tests 
in cold urticaria if the serum is injected and the ice cube 
placed immediately thereafter (a minimum of 2-4 hr 
passive sensitization appeared necessary) . Nor is a posi-
tive response seen if the site is chilled with an ice cube 
and the serum then injected. 
Soter: The time-dependent release of ECF-A was 
demonstrated in the cold-challenged extremities with a 
peak between 2 and 5 min and a return to baseline by 20 
min. The identity of the released eosinophil chemotactic 
activity with ECF-A was confirmed by chromatography on 
Sephadex G-10. 
Kirkpatrick: Do eosinophils occur in the lesions of 
cold urticaria? 
Soter: Eosinophils do not accumulate in tissue biopsy 
specimens from lesional sites examined during the first 30 
mIll. 
Kaplan: Eosinophils are not seen when cold urticaria 
lesions are biopsied. This is really not surprising because 
a concentration gradient of mediators is required over 
time in order to obtain a chemotactic response; the 
mediator release observed in cold urticaria is rapid and 
the mediators are rapidly cleared into the circulation so 
that there may be insufficient time for the stimulation of 
cell movement. Furthermore, the large quantities of 
histamine and ECF -A released into the tissue space 
would rapidly deactivate any eosinophils entering the 
periphery of the reaction and inhibit their further move-
ment. 
Kantor: Why don't antihistaminics work well in cold 
urticaria? 
Kaplan: The drug of choice for cold urticaria is 
cyproheptadine (Periactin) which controls the patient's 
symptoms and turns the ice cube test negative. Diphen-
hydramine, a much better antihistamine, is not as 
effective. Cyproheptadine is said to have antiserotonin 
and antibradykinin activity, but we found no evidence of 
release of measurable amounts of these mediators. I 
would suggest that cyproheptadine has some other activ-
ity such as upon the release of mediators rather than 
simply antagonizing their effect that we do not appreci-
ate. I do not think we can achieve a sufficient concentra-
tion of diphenhydramine at the relevant skin site to 
inhibit the action of histamine because the dose required 
would cause severe side effects . 
Cohen: A still unexplained clinical observation is the 
reported superiority of one of the weakest antihistaminic 
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preparations by in vitro standards, hydroxyzine, to 
suppress spontaneous and pressure-induced whealing in 
chronic urticaria of unknown etiology. Can your patients 
with clear-cut demonstrable histamine or cholinergic-
related mechanisms possibly serve as models to help 
clarify this pharmacologic effect of hydroxyzine; have you 
had an opportunity to evaluate this preparation in either 
cold or cholinergic urticaria? 
Kaplan: The efficacy of hydroxyzine in cholinergic 
urticaria may relate to inhibition of the neural reflex 
since it does have effects upon the central nervous 
system. This may be more important than its antihista-
mine activity and may also explain its effectiveness in 
relieving pruritus in urticaria of diverse etiologies. 
Windhorst: Classical concepts of cholinergic urticaria 
emphasize that the pattern of disease and the cholinergic 
innervation of eccrine sweat glands suggest that the 
abnormal event is peculiar to this particular site of 
acetylcholine secretion. Have you found any evidence to 
suggest that this is or is not the case? 
Kaplan: I did indicate that innervation of the sweat 
glands is by cholinergic fibers and that injection of 
cholinergic agents leads to the type of wheal and flare 
reaction seen in cholinergic urticaria. It is unknown 
whether this is a direct effect of the cholinergic stimulus 
or whether other mediators are recruited. I presented 
some evidence to support the latter alternative although 
an immunologic mechanism is not evident. 
Austen: One might speculate that the mast cell 
mediators initiate the cholinergic skin reflex by analogy 
to the action of histamine on airway irritant receptors. 
Weston: You mention that histamine itself is chemo-
tactic for eosinophils. How does histamine compare in 
potency to other known chemotactic substances for 
eosinophils, such as ECF-A, C5a, and the Hageman 
factor-activated plasma chemotactants? 
Kaplan: We have shown that histamine is indeed 
selectively chemotactic for eosinophils at concentrations 
between 10 and 300 ng/ml (peak at 120 ng/ml); this I 
activity diminishes as the dose increases to 1000 ng/ml. 
This diminished response at high doses is reversed by H2 
receptor antagonists . As Dr. Austen noted, mast cells 
release a high-molecular-weight chemotactic factor 
which is not selective for eosinophils, peptides which 
preferentially attract eosinophils (ECF -A), and hista-
mine. The net cellular response involves all of them ; 
however, their qualitative effect upon the cells is not the 
same, and their relative quantitative contribution has 
not been assessed. 
Rocklin: In view of the fact that there are two types of 
histamine receptors and that classic HI-receptor antago-
nists are ineffective in the treatment of patients with cold 
urticaria, have you attempted to treat these patients with 
H 2-receptor blockers such as metiamide or burimamide? 
Kaplan: We have not tried H2 receptor antagonists in 
the treatment of cold urticaria. The classical wheal and 
flare response appears to involve the interaction of 
histamine with HI receptors . 
